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Godofredo Santiago, MD,* Cosme Cruz, MD,* Francis Dumler, MD,* Pedro Cortes, MD,* Stanley 
Dienst, MD,** Sandra Parnell, RN, BS, Maxine Uniewski, RN, and Nathan W. Levin, MD* 
Eighty-one patients with chronic renal failure associated 
with or secondary to diabetic nephropathy were treated with 
dialysis and/or transplant. Twenty-five had juvenile di-
abetes and 56 had adult onset diabetes. Juvenile diabetics 
did poorly on hemodialysis with 13 patients having a 19% 
four-year survival rate, whereas those who had cadaveric 
transplantation did well with a four-year patient and graft 
survival rate of 56% in nine patients. The three juvenile 
diabetics who received related kidney grafts are presently 
alive with good function. Patients with adult onset diabetes 
did well on hemodialysis with a four-year survival rate of 
63% in 45 patients. In this last group 11 patients received 
cadaveric transplants, but none survived 18 months. 
A major cause of death in diabetes mellitus is diabetic 
nephropathy with progression to terminal renal failure. 
Death from uremia occurs at a mean of 2.7 years from the 
time renal insufficiency is initially detected unlessdialysisor 
transplantation are performed. 
There has been reluctance to accept uremic diabetics to 
chronic hemodialysis programs because multiple diabetic 
complications including retinopathy, neuropathy, autono-
mic disorder, and arterial disease are already present. As 
dialysis became more widely available, it became clear that 
chronic dialysis treatment of diabetics is unsatisfactory 
compared to nondiabetic patients in regard to mortality and 
morbidity.^'" Rapid progression of retinopathy and neuropa-
thy has been observed. It has also been reported that 70% of 
all diabetics are dead three years after dialysis' has been 
initiated. 
Najarian and others have recently demonstrated the success 
of renal transplantation in juvenile onset diabetes.'' Eighty-
eight of 132 patients (67%) were alive, and 81 of 132 grafts 
were function ing from one to five years after transplantation. 
Ninety-six kidneys were obtained from living related do-
nors, and 36 were from cadaver donors. They strongly 
advocated thattransplantation be the treatmentof choice for 
juvenile diabetics in spite of the higher risk involved. 
In order to determine the advantages and disadvantages of 
hemodialysis and transplantation as treatment for end-stage 
kidney disease in diabetes, we have analyzed our experi-
ence in 81 diabetic patients over a four-year period. 
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Materials and Methods 
In four years, we have treated 81 patients with insulin 
and/ororal-agent dependent diabetes. Age and sex charac-
teristics are summarized in Table I. Twenty-five were juve-
nile onset diabetics, and 56 were adult onset diabetics. 
Patients who had the diagnosis of diabetes mellitus before 
age 18 were considered juvenile onset diabetics, while those 
diagnosed after 18 were considered adult onset diabetics. 
Although some error may have been introduced due to the 
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Fig.1 
Patient Survival on Dialysis 
Patients who had graft failure remain in the transplant group. 
presence of young patients with maturity onset diabetes, the 
clinical picture of our patients diagnosed with juvenile 
diabetes has not been compatible with this possibility. 
Twenty-four patients received a transplant, and 56 were 
treated with chronic intermittent hemodialysis. Patients 
were transplanted according to the procedure described by 
Simmons, eta/.'Those on hemodialysis were dial yzed three 
times a week for an average of four hours per treatment, 
using hollow fiber kidneys with 2.5 square meter surface 
area and with single-pass dialysis machines. 
Cumulative patient and kidney survival statistics were cal-
culated by the life table method.° Causes of death were 
compiled and tabulated in each group. 
Results 
Fifty-one of the 81 diabetic patients (63%) are alive with a 
mean treatment period of 19.8 months. Figure 1 compares 
thecumulative patient survival of adult and juvenile diabet-
ics to the nondiabetic dialysis population. Both adult diabet-
ics and nondiabetics have a similar four-year survival rate. 
However, juvenile diabetics did not benefit from dialysis. 
In Figure 2, our diabetic patients are divided according to 
juvenile or adult onset group and according to donor 
source. Our experience in related diabetic transplants is 
limited to three patients, who are all alive at this time. 
Juvenile, cadaveric transplant patients did well with 57% 
alive atfouryears, in contrast to adult onset diabetics, none 
of whom survived over 18 months after transplantation. 
Figure 3 shows the data on kidney graft survival. To date, the 
three juvenile diabetics have good functioning grafts at 56, 
36, and 30 months, respectively. The juvenile diabetic. 
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Kidney Graft Survival 
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cadaver kidney did comparatively well with a 56% four-
year survival rate. 
The causes of death are listed in Table II. The source of this 
information was the autopsy reports of 13 patients and the 
death certificates of the 14 patients who did not have 
postmortem exam inations. Compi ications of d iabetes as the 
primary or secondary cause of death were considered when 
death was associated with severe hypo- or hyperglycemia 
and/or severe autonomic neuropathy. Complications of 
d iabetes accounted for the greatest number of deaths among 
juvenile diabetics on dialysis, while cardiovascular deaths 
predominate in the adult onset patients who had received 
transplants. Infection as a cause of death was highest in the 
juvenile diabetic transplants (100%), with septicemia being 
the most common infection. Other infections consisted of 
meningitis, staphylococcal empyema, and hyperinfection 
with Strongyloides. Ofthe infectious causes of death in adult 
diabetic transplants (50%), 30% were dueto septicemia and 
20% to pneumonia. Only 16% of those adult onset diabetics 
on hemodialysis died with infection, while none of the 
juvenile diabetics on hemodialysis did so. 
Discussion 
Diabetic nephropathy causing renal failure is the second 
most common diagnosis in the end-stage renal disease 
program at Henry Ford Hospital. It was found in 81 of 354 
patients (23%) who presented with chronic renal failure 
during the study period. This increase in diabetic patients 
maybe due in part to the active diabetes clinic at our center 
as well as to the recent trend towards more liberal dialysis 
acceptance pol icies here and elsewhere. In our total of 354 
patients, hypertensive nephrosclerosis was the lead ing diag-
nosis (31%). This differs from reports at other centers where 
chronic glomerulonephritis is the most commonly reported 
cause of renal failure. 
Regardless of diabetic complications, patients with terminal 
renal failure were unselected. Except for those with active 
infection, recent myocardial infarction, age over 60 years, 
and extreme debility, transplantation was encouraged. The 
final decision remained with the patient, who, after the 
possible outcomes were explained, could elect to stay on 
hemodialysis or be transplanted. Those who chose to stay on 
hemodialysis did so because of fear of major surgery, social 
reasons, and, in a few cases, religious belief. 
Our experience with juvenile onset diabetic patients sup-
ports the conclusions of previous series.' Our results show 
that this group of patients did poody on chronic hemo-
dialysis, with 19% cumulative life table survival at four 
years. However, with cadaveric transplantation, the patient 
survival and graft survival at four years is 56%, which does 
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not differ significantly from the rate for the nondiabetic 
cadaver transplant group. 
The superiority of transplantation over hemodialysis as a 
method of managing end-stage kidney disease due to juve-
nile onset diabetes is impressive enough to make it the 
treatment of choice in such patients. This should not hide the 
fact that there is a higher incidence of complications 
associated with marked increased morbidity in juvenile 
diabetics than in nondiabetic transplantation patients. It has 
also been reported that diabetic lesions may reoccur in the 
transplanted kidney, although this factor has not yet caused 
functional deterioration in the transplanted graft.^" 
Juvenile diabetics have rapid progression of their diabetic 
complications which contributed directly in most cases to 
their early death on hemodialysis therapy Stabilization of 
these complications has been reported in previous trans-
plants, which may in part explain their increased survival 
after successful kidney transplantation. Infection remains 
the most common cause of death after transplantation. 
In marked contrast, adult onset diabetics, in spite of already 
advanced age with onset of uremia, did reasonably well on 
chronic hemodialysis therapy The patient survival at four 
years of 63% does not significantly differ from the rate for the 
nondiabetic dialysis population. As a group, adult onset 
diabetics did very poorly with transplantation with all of our 
patients dead at 18 months. 
This find ing would suggest that adult onset diabetic patients 
with end-stage kidney disease should be treated with hemo-
dialysis or peritoneal dialysis therapy rather than by renal 
transplantation. Most of the mortality in this group was 
caused by death from coronary vascular disease, which 
suggests that advanced artherosclerosis is usually present by 
the time their kidneys fail. 
In some centers," chronic peritoneal dialysis is used pre-
dominantly fortreating chronic renal failure due to diabetes. 
Its major advantage is that it can be carried out without the 
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use of heparin, which has been claimed to aggravate retinal 
hemorrhage leading to deterioration of vision. Our experi-
ence with this form of therapy is limited to four patients, for 
whom it has been a satisfactory substitute when hemo-
dialysis was not feasible. We have used it in cases of lossof 
all possible access sites, severe cardiovascular instability, 
and severe autonomic dysfunction causing orthostatic hy-
potension. Advances in peritoneal dialysis technology may 
reduce the associated complications such as infections, 
make it less time consuming, and thus make it a more 
attractive alternative than in its present form. 
In this series, except for a few recent cases, dialysis and/or 
transplantation were initiated when the renal function was 
approximatelySml/minorless. More recently, Kussman has 
advocated that transplantation in juvenile diabetics be 
started earlier, when the serum creatinine approaches 
5mg/100ml, in order to avoid irreversible complications.' 
Whether this approach would decrease the morbidity and 
mortality in juvenile diabetic nephropathy remains to be 
proven. 
Summary 
In the light of our experience and that of others, the 
disheartening results in treating diabetic patients with 
chronic renal failure as reported in the earl ier days may no 
longer be considered true. Proper selection of the form of 
therapy may significantly enhance the survival and well-
being of uremic diabetic patients. The results of our series 
encourage us to continue the active treatment of renal 
failure due to diabetes and, in general, to recommend 
transplantation for the juvenile onset group and hemo-
dialysis for the adult onset group. 
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